Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04261439
Title A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU | BEL

No variant requirements are available.